Hemostatic radiotherapy in carcinoma of the uterine cervix.
OBJECTIVE
To evaluate the treatment of hemorrhagic carcinoma of the uterine cervix with hemostatic radiotherapy (external and intracavitary radiotherapy).


METHODS
Twenty cases of refractory hemorrhagic carcinoma of the uterine cervix receiving hemostatic radiotherapy between April 1987 and May 1992 were analyzed. The age of the patients ranged between 30 and 60 years with a median of 42 years.


RESULTS
The mean tumor volume was 130 mm3; all cases were classified as FIGO stage IIb (n = 8), IIIb (n = 11) or IVa (n = 1). Radiotherapy was carried out either by the external or intracavitary technique. The control of hemorrhage was 100% within 12-48 h after radiotherapy. However 85% of patients failed locally in the form of residual, recurrent pelvic or metastatic disease, within 24 months of follow-up.


CONCLUSIONS
Hemorrhagic cervical cancer has a poor prognosis.
Biswal
B M
BM
Department of Radiation Oncology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Lal
P
P
Rath
G K
GK
Mohanti
B K
BK
D000328:Adult; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000401:mortality / Q000532:radiotherapy*; D005260:Female; D006489:Hemostatic Techniques; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D011879:Radiotherapy Dosage; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000150:complications / Q000401:mortality / Q000532:radiotherapy*; D014592:Uterine Hemorrhage / Q000209:etiology / Q000532:radiotherapy*